Table 2.
Human Tissue Type | Cell Line | Cytotoxicity (µg/ml) | |
ID50 | ID90 | ||
T-cell leukemia | CEM | 0.047±0.011 | 0.1±0.007 |
Myelodysplasia syndromes | Sp | 0.085±0.02 | 0.25±0.02 |
Melanoma | DND-1A | 0.25±0.08 | 0.51±0.04 |
Renal cancer | 786-0 | 0.042±0.006 | 0.08±0.01 |
Breast cancer | MCF-7 | 0.12±0.02 | 0.49±0.05 |
Non-small cell lung cancer | NCl-H522 | 0.05±0.01 | 0.09±0.01 |
Colon cancer | HCT-116 | 0.09±0.02 | 0.41±0.05 |
Lymphoma | Daudi/wt* | 0.007±0.001 | 0.05±0.025 |
Lymphoma | Daudi/MDR* | 0.005±0.001 | 0.06±0.004 |
Normal lymphocytes | PHA stimulated† | 2.5±0.3 | 5.5±0.6 |